Conkling PR - Search Results

1

Thrombosis in acute promyelocytic leukemia.

Rashidi A, Silverberg ML, Conkling PR, Fisher SI. Rashidi A, et al. Among authors: conkling pr. Thromb Res. 2013 Apr;131(4):281-9. doi: 10.1016/j.thromres.2012.11.024. Epub 2012 Dec 23. Thromb Res. 2013. PMID: 23266518 Review.

2

Acute promyelocytic leukemia following solid organ transplantation.

Rashidi A, Conkling PR, Fisher SI. Rashidi A, et al. Among authors: conkling pr. Ann Hematol. 2016 Jan;95(1):169-171. doi: 10.1007/s00277-015-2524-7. Epub 2015 Oct 10. Ann Hematol. 2016. PMID: 26453075 Review. No abstract available.

3

Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes.

Conkling PR, Greenberg CS, Weinberg JB. Conkling PR, et al. Blood. 1988 Jul;72(1):128-33. Blood. 1988. PMID: 3134064 Free article.

4

Extended dosing with CC-486 (oral azacitidine) in patients with myeloid malignancies.

Savona MR, Kolibaba K, Conkling P, Kingsley EC, Becerra C, Morris JC, Rifkin RM, Laille E, Kellerman A, Ukrainskyj SM, Dong Q, Skikne BS. Savona MR, et al. Am J Hematol. 2018 Oct;93(10):1199-1206. doi: 10.1002/ajh.25216. Epub 2018 Sep 3. Am J Hematol. 2018. PMID: 30016552 Free PMC article. Clinical Trial.

5

Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding.

Conkling PR, Patton KL, Hannun YA, Greenberg CS, Weinberg JB. Conkling PR, et al. J Biol Chem. 1989 Nov 5;264(31):18440-4. J Biol Chem. 1989. PMID: 2808383 Free article.

6

Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function.

Conkling PR, Chua CC, Nadler P, Greenberg CS, Doty E, Misukonis MA, Haney AF, Bast RC Jr, Weinberg JB. Conkling PR, et al. Cancer Res. 1988 Oct 1;48(19):5604-9. Cancer Res. 1988. PMID: 3046744 Clinical Trial.

7

Human mononuclear phagocyte transglutaminase activity cross-links fibrin.

Conkling PR, Achyuthan KE, Greenberg CS, Newcomb TF, Weinberg JB. Conkling PR, et al. Thromb Res. 1989 Jul 1;55(1):57-68. doi: 10.1016/0049-3848(89)90456-8. Thromb Res. 1989. PMID: 2571199

8

Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain.

Weisberg LJ, Shiu DT, Conkling PR, Shuman MA. Weisberg LJ, et al. Among authors: conkling pr. Blood. 1987 Aug;70(2):579-82. Blood. 1987. PMID: 3607290 Free article.

9

A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.

Murray Stewart T, Von Hoff D, Fitzgerald M, Marton LJ, Becerra CHR, Boyd TE, Conkling PR, Garbo LE, Jotte RM, Richards DA, Smith DA, Stephenson JJ Jr, Vogelzang NJ, Wu HH, Casero RA Jr. Murray Stewart T, et al. Among authors: conkling pr. Cancer Chemother Pharmacol. 2021 Jan;87(1):135-144. doi: 10.1007/s00280-020-04201-1. Epub 2020 Nov 19. Cancer Chemother Pharmacol. 2021. PMID: 33215270 Free PMC article. Clinical Trial.

10

A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors.

Becerra CR, Conkling P, Vogelzang N, Wu H, Hong S, Narwal R, Liang M, Tavakkoli F, Pandya N. Becerra CR, et al. Cancer Chemother Pharmacol. 2014 Nov;74(5):917-25. doi: 10.1007/s00280-014-2567-9. Epub 2014 Aug 23. Cancer Chemother Pharmacol. 2014. PMID: 25149088 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page